Large Study Finds No Link Between Tylenol Use During Pregnancy and Autism
A comprehensive study published in JAMA Pediatrics, analyzing data from over 1.5 million children born in Denmark between 1997 and 2022, has found no causal link between acetaminophen (Tylenol) use during pregnancy and the development of autism in children. The research revealed that 1.8% of children exposed to the drug developed autism, compared to 3.0% of those unexposed. This finding directly contradicts recent assertions by former President Donald Trump, who urged pregnant women to avoid Tylenol without substantive evidence, prompting the FDA to consider safety label updates. The study aligns with previous Swedish research involving siblings, which also found no causal connection. Medical organizations, including the American College of Obstetricians and Gynecologists, and Kenvue, the manufacturer of Tylenol, have strongly supported these findings, emphasizing the drug's safety and expressing concern over misinformation posing health risks to expecting mothers. The article highlights the conflict between political rhetoric and scientific consensus regarding prenatal care and autism causes.
Wire timeline
Large Study Finds No Link Between Tylenol Use During Pregnancy and Autism
A comprehensive study published in JAMA Pediatrics, analyzing data from over 1.5 million children born in Denmark between 1997 and 2022, has found no causal link between acetaminophen (Tylenol) use during pregnancy and the development of autism in children. The research revealed that 1.8% of children exposed to the drug developed autism, compared to 3.0% of those unexposed. This finding directly contradicts recent assertions by former President Donald Trump, who urged pregnant women to avoid Tylenol without substantive evidence, prompting the FDA to consider safety label updates. The study aligns with previous Swedish research involving siblings, which also found no causal connection. Medical organizations, including the American College of Obstetricians and Gynecologists, and Kenvue, the manufacturer of Tylenol, have strongly supported these findings, emphasizing the drug's safety and expressing concern over misinformation posing health risks to expecting mothers. The article highlights the conflict between political rhetoric and scientific consensus regarding prenatal care and autism causes.
abcnews